ABCG2 is a potential biomarker causing multidrug resistance (MDR) in Non-Small Cell Lung Cancer (NSCLC).We conducted this study to investigate whether Icoti
Purpose: To investigate the mechanism of pretreatment with EGFR inhibitors sensitizes cancer cells to DNA-damaging therapy.Implementation &Methodology: MTT